Envista (NYSE:NVST) Stock Price Target Raised at UBS Group

Envista (NYSE:NVST) had its price target boosted by investment analysts at UBS Group from $27.00 to $29.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group‘s target price points to a potential upside of 16.43% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Morgan Stanley set a $23.00 target price on shares of Envista in a report on Thursday, August 6th. Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday. Leerink Partners cut their price objective on Envista from $35.00 to $32.00 and set an “outperform” rating for the company in a research report on Wednesday, October 14th. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 5th. Finally, JPMorgan Chase & Co. upgraded Envista from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $29.00 to $32.00 in a research note on Thursday, September 3rd. Six investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, Envista currently has an average rating of “Hold” and a consensus price target of $29.00.

Envista Stock Down 8.4%

NVST traded down $2.28 during trading on Thursday, reaching $24.91. 5,487,971 shares of the stock were exchanged, compared to its average volume of 2,957,959. The stock has a market cap of $4.00 billion, a P/E ratio of 42.94, a price-to-earnings-growth ratio of 1.26 and a beta of 0.94. Envista has a twelve month low of $18.77 and a twelve month high of $30.42. The stock’s 50 day moving average price is $24.49 and its two-hundred day moving average price is $25.74. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm had revenue of $691.50 million for the quarter, compared to analyst estimates of $688.74 million. During the same period in the prior year, the firm posted $0.32 earnings per share. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. Equities analysts expect that Envista will post 1.53 EPS for the current year.

Insider Activity

In related news, SVP Mischa Reis sold 8,000 shares of Envista stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of NVST. Corient Private Wealth LP boosted its holdings in shares of Envista by 35.8% during the second quarter. Corient Private Wealth LP now owns 703,864 shares of the company’s stock worth $18,547,000 after acquiring an additional 185,687 shares during the period. GSA Capital Partners LLP bought a new position in shares of Envista during the second quarter worth approximately $2,039,000. Legal & General Group Plc bought a new position in shares of Envista during the second quarter worth approximately $5,987,000. WINTON GROUP Ltd boosted its stake in Envista by 247.9% in the 2nd quarter. WINTON GROUP Ltd now owns 192,055 shares of the company’s stock valued at $5,061,000 after purchasing an additional 136,855 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in Envista in the 2nd quarter valued at $1,464,000.

Trending Headlines about Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q3 results topped estimates: Envista earned $0.40 per share, ahead of analyst expectations of $0.35–$0.36, on revenue of $691.5 million versus estimates of about $688.7 million. Revenue grew 3.2% year over year, and EPS increased from $0.32 a year earlier. Article: Envista Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Raised 2026 outlook: Management lifted its 2026 earnings guidance, citing pricing and productivity gains. Better near-term expectations may support investor sentiment. Article: Envista Q3 Earnings Call Highlights
• Neutral Sentiment: Valuation views point to potential upside: One analysis describes NVST as about 8% undervalued based on earnings guidance, while a separate report cites an average analyst target price of $28.86. These are estimates, not guarantees. Article: Envista Could Be 8% Undervalued Article: Average Target Price
• Negative Sentiment: China presents a margin risk: Procurement reforms in China could pressure margins as Envista moves into 2027, tempering the positive impact of the higher 2026 outlook. Article: Envista Q3 Earnings Call Highlights

About Envista

Envista Holdings Corporation (NYSE: NVST) is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral health professionals.

Envista’s portfolio includes dental implants, orthodontic systems, digital imaging and workflow solutions, dental consumables, treatment equipment and related technologies. Its brands include Nobel Biocare, Ormco, DEXIS and Kerr, which provide products and services spanning implant dentistry, orthodontics, diagnostic imaging, restorative care and general dental practice management.

Envista was established as an independent public company in 2019 following its separation from Danaher Corporation.